The FDA Just Approved Another Promising Immunotherapy for Cancer – Gizmodo
Gizmodo |
The FDA Just Approved Another Promising Immunotherapy for Cancer
Gizmodo The FDA’s approval of Yescarta, manufactured by Kite Pharma, comes just a few months after its first approval—an indication of just how quickly the field of immunotherapy is moving. Several other companies also have CAR-T therapies in the works. Cutting-edge immunotherapy treatment approved for another deadly cancerWashington Post Gilead cancer immunotherapy wins US approval with $373000 priceNasdaq F.D.A. Approves Second Gene-Altering Treatment for Cancer – The …New York Times PR Newswire (press release) –Markets Insider –The San Diego Union-Tribune –FDA.gov all 106 news articles » |
|
FDA Approves Gilead Cancer Gene Therapy
HuffPost (Reuters) – U.S. regulators approved on Wednesday a new therapy for a type of lymphoma, which was developed by Gilead Science Inc’s (GILD.O) Kite Pharma, marking the second approval for this potentially revolutionary approach to fighting cancer. |
|
CRISPR Gene Editing Aims to Improve ‘Orphan Crops’
agprofessional.com Nigel and other researchers are working to stay ahead of cassava brown streak using a new technology: Clustered Regularly Interspaced Short Palindromic Repeat, or CRISPR. CRISPR allows geneticists to identify a specific genetic sequence within an … |